Zio Demand Drives 20% Revenue Growth For iRhythm, Bullish Sentiment Builds Among Analysts
1. iRhythm reported Q1 2025 revenue of $158.7 million, exceeding estimates. 2. Adjusted EPS loss narrowed to 95 cents, outperforming consensus estimates. 3. Launch of Zio ECG system in Japan enhances international growth prospects. 4. Wells Fargo and Baird raise price targets, indicating positive market sentiment. 5. iRhythm projects 2025 sales guidance of $690-$700 million, above previous estimates.